跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,934 条关于
“TYK2-inhibitor”
全部
19,934
临床试验
9,780
药物
4,069
机构
21
资讯
6,064
去年
Bristol Myers' TYK2 Inhibitor Shows Promise in Phase 3 Psoriatic Arthritis Trials
去年
Alumis' A-005 Shows Promise in Phase 1 Trial for CNS Penetration and TYK2 Inhibition
去年
Takeda's Oral TYK2 Inhibitor Zasocitinib Advances Development for Multiple Autoimmune Conditions
9个月前
Lynk Pharmaceuticals Receives FDA IND Approval for Brain-Penetrant TYK2 Inhibitor LNK01006 Targeting Neuroinflammatory Diseases
10个月前
Sudo Biosciences Reports Positive Phase 1 Results for Brain-Penetrant TYK2 Inhibitor SUDO-550 in Neuroinflammatory Diseases
9个月前
Galapagos' TYK2 Inhibitor GLPG3667 Meets Primary Endpoint in Dermatomyositis Phase 3-Enabling Study
去年
InnoCare's TYK2 Inhibitor ICP-488 Demonstrates Promising Phase II Results in Psoriasis Patients
9个月前
InnoCare Initiates Global Phase II Trial of TYK2 Inhibitor Soficitinib for Prurigo Nodularis Treatment
去年
InnoCare Pharma's TYK2 Inhibitor ICP-488 Shows Promising Phase II Results for Psoriasis Treatment
去年
InventisBio's D-2570 Shows Promise in Phase 2 Psoriasis Trial
第 1 页,共 607 页
上一页
下一页